Taipei, Dec. 6 (CNA) All participants in the Phase 3 clinical trial of Taiwan-based Medigen Vaccine Biologics Corp.'s COVID-19 vaccine in Paraguay have now received two shots of either the Medigen or AstraZeneca vaccine, the company said Monday.
Taipei, Nov. 4 (CNA) Taiwan-based Medigen Vaccine Biologics Corp. said Thursday that all 1,030 participants in its Phase 3 clinical trial in Paraguay have received their first vaccine shot of either the Medigen or AstraZeneca COVID-19 vaccines.
TAIPEI, Oct. 27, 2021 /PRNewswire/ Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be
Taiwan-based Medigen Vaccine Biologics Corp announced on October 27, 2021, the MVC-COV1901 vaccine candidate is one of two finalists recommended by an independent vaccine prioritization advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv).